Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

51.77
+0.50500.99%
Volume:445.69K
Turnover:22.71M
Market Cap:4.10B
PE:6.89
High:51.81
Open:51.04
Low:49.86
Close:51.26
Loading ...

PTC Therapeutics Shares Down 15.9% Premarket After Co Reports Mid-Stage Data for Neurological Disease Drug

THOMSON REUTERS
·
05 May

PTC Therapeutics Inc: PTC518 Pivot-Hd Study Achieves Primary Endpoint

THOMSON REUTERS
·
05 May

PTC Therapeutics Inc - Favorable Safety Profile With No Treatment-Related Nfl Spikes

THOMSON REUTERS
·
05 May

PTC Therapeutics’ PTC518 achieves primary endpoint in Phase 2 Huntington’s study

TIPRANKS
·
05 May

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 May

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?

Zacks
·
29 Apr

PTC Therapeutics Inc : Leerink Partners Raises Target Price to $52 From $50

THOMSON REUTERS
·
29 Apr

Rpt-Ema Says Chmp Recommended Granting Conditional Marketing Authorisation for Ziihera (Zanidatamab)

THOMSON REUTERS
·
25 Apr

BRIEF-EMA Says Tepezza Received Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Thyroid Eye Disease

Reuters
·
25 Apr

Rpt-Ema Says Sephience (Sepiapterin) Got Positive Opinion From Chmp for Treatment of Hyperphenylalaninaemia in Adults & Children With Phenylketonuria

THOMSON REUTERS
·
25 Apr

Corrected-Ema Says Chmp Will Re-Examine (Not 'Requested Re-Examination of') Opinion Adopted for Marketing Authorisation Holder for Kisunla (Donanemab)

THOMSON REUTERS
·
25 Apr

Rpt-Ema Says Chmp Recommends Conditional Marketing Authorisation for Duvyzat (Givinostat), as Treatment for Dmd in Patients From Age Six Who Can Walk

THOMSON REUTERS
·
25 Apr

Ema Says Sephience (Sepiapterin) Got Positive Opinion From Chmp for Treatment of Hyperphenylalaninaemia in Adults & Children With Phenylketonuria

THOMSON REUTERS
·
25 Apr

PTC Therapeutics Says Potential Phenylketonuria Drug Receives EU Panel's Positive Opinion

MT Newswires Live
·
25 Apr

BRIEF-PTC Therapeutics Receives Positive CHMP Opinion For Sephience™ (Sepiapterin) For The Treatment Of Children And Adults Living With Phenylketonuria (PKU)

Reuters
·
25 Apr

PTC Therapeutics Inc - European Commission Expected to Ratify Sephience Authorization in Two Months

THOMSON REUTERS
·
25 Apr

PTC Therapeutics Receives Positive Chmp Opinion for Sephience™ (Sepiapterin) for the Treatment of Children and Adults Living With Phenylketonuria (Pku)

THOMSON REUTERS
·
25 Apr

PTC Therapeutics Inc: European Launch Preparations Underway

THOMSON REUTERS
·
25 Apr

PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

PR Newswire
·
25 Apr

PTC Therapeutics CEO Makes Significant Stock Move

TIPRANKS
·
25 Apr